Recent Advances in Small Molecule Inhibitors for the Treatment of Osteoarthritis
Osteoarthritis refers to a degenerative disease with joint pain as the main symptom, and it is caused by various factors, including fibrosis, chapping, ulcers, and loss of articular cartilage. Traditional treatments can only delay the progression of osteoarthritis, and patients may need joint replac...
Main Authors: | Jianjing Lin, Shicheng Jia, Weifei Zhang, Mengyuan Nian, Peng Liu, Li Yang, Jianwei Zuo, Wei Li, Hui Zeng, Xintao Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/5/1986 |
Similar Items
-
Selumetinib - a potential small molecule inhibitor for osteoarthritis treatment
by: Xiaohang Zheng, et al.
Published: (2022-09-01) -
Small molecule inhibitors of osteoarthritis: Current development and future perspective
by: Dan Liu, et al.
Published: (2023-04-01) -
Small molecule inhibitors targeting the cancers
by: Gui‐Hong Liu, et al.
Published: (2022-12-01) -
Survivin Small Molecules Inhibitors: Recent Advances and Challenges
by: Najah Albadari, et al.
Published: (2023-02-01) -
JD-312 – A novel small molecule that facilitates cartilage repair and alleviates osteoarthritis progression
by: Jingduo Gao, et al.
Published: (2024-01-01)